Treatment of Extrahepatic Diseases Caused by Hepatitis B and Hepatitis C Viruses

Merle, Philippe; Trépo, Christian

doi:10.1002/9780470987131.ch51

Cited by 1 publication

(1 citation statement)

References 104 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In an average 38% of HCV infection patients, at least one extrahepatic symptom is observed during the course of the disease. [11] The mortality and morbidity related to coronary heart disease have increased in patients in MS that includes various disorders, such as abdominal obesity, lipid metabolism disorders, hypertension, diabetes mellitus, insulin resistance with or without glucose intolerance, microalbuminuria, thrombosis, and inflammation tendency. [12] Insulin resistance is associated with a tendency to develop characteristics of MS, such as dyslipidemia and hypertension.…”

Section: Discussionmentioning

confidence: 99%

Incidence of Metabolic Syndrome in Anti-HCV Positive Patients

Işık¹

2020

South Clin Ist Euras

View full text Add to dashboard Cite

Objective: Research has shown that hepatitis C infection, metabolic syndrome (MS), and non-alcoholic fatty liver syndrome are associated. This study was designed to assess the parameters of MS in people with hepatitis C antibodies. Methods:We enrolled 104 patients, including 52 men and 52 women who visited our hospital and had anti-hepatitis C virus (HCV) positivity. In the patient group, different examinations were performed as per the MS criteria in the Adult Treatment Panel (ATP) III and International Diabetes Federation (IDF) guidelines. Results:As per the ATP III criteria, the prevalence of MS was 36.5% (n=38) in the total population, 55.8% (n=29) in women, and 17.3% (n=9) in men in our study. When the IDF criteria were applied, the MS prevalence was 48.1% (n=50) in the total population, 65.4% (n=34) in women, and 30.8% (n=16) in men. Conclusion:In our study, the prevalence of MS was significantly higher in female patients with HCV antibodies than in male patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Incidence of Metabolic Syndrome in Anti-HCV Positive Patients

Işık¹

2020

South Clin Ist Euras

View full text Add to dashboard Cite

show abstract

Treatment of Extrahepatic Diseases Caused by Hepatitis B and Hepatitis C Viruses

Cited by 1 publication

References 104 publications

Incidence of Metabolic Syndrome in Anti-HCV Positive Patients

Incidence of Metabolic Syndrome in Anti-HCV Positive Patients

Contact Info

Product

Resources

About